World's Best Scientists 2026 revealed!
Jonathan L. Bramson

Jonathan L. Bramson

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 61 3272 3016 82 72 213 10755

Jonathan L. Bramson publications per year

The chart shows the history of publications by Jonathan L. Bramson between 1991 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jonathan L. Bramson published across 35 years, from 1991 to 2025, averaging 9.3 papers a year. Output peaked at 65 publications in 2023. 47 of the 325 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1991 to 2025. Vertical axis: number of publications, 0 to 65. Peak 65 publications in 2023. 1991: 1 publication 1992: 1 publication 1993: 2 publications 1994: 0 publications 1995: 7 publications 1996: 3 publications 1997: 3 publications 1998: 3 publications 1999: 2 publications 2000: 6 publications 2001: 2 publications 2002: 3 publications 2003: 5 publications 2004: 7 publications 2005: 3 publications 2006: 5 publications 2007: 11 publications 2008: 7 publications 2009: 12 publications 2010: 10 publications 2011: 14 publications 2012: 9 publications 2013: 9 publications 2014: 12 publications 2015: 8 publications 2016: 16 publications 2017: 8 publications 2018: 14 publications 2019: 6 publications 2020: 9 publications 2021: 6 publications 2022: 9 publications 2023: 65 publications 2024: 23 publications 2025: 24 publications
1991 2025

325 publications in total across all disciplines

View publications per year as a table
Jonathan L. Bramson: publications per year, 1991 to 2025
Year Publications
1991 1
1992 1
1993 2
1994 0
1995 7
1996 3
1997 3
1998 3
1999 2
2000 6
2001 2
2002 3
2003 5
2004 7
2005 3
2006 5
2007 11
2008 7
2009 12
2010 10
2011 14
2012 9
2013 9
2014 12
2015 8
2016 16
2017 8
2018 14
2019 6
2020 9
2021 6
2022 9
2023 65
2024 23
2025 24
Total 325
Download as CSV

Jonathan L. Bramson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jonathan L. Bramson sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 212–221 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 213 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158 213
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Jonathan L. Bramson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jonathan L. Bramson sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 60–61 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197 61
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Jonathan L. Bramson is affiliated with McMaster University in Canada and has contributed extensively to medical research, with a focus on oncology, immunology, and molecular biology. Their body of work represents a significant engagement with the study of immune cell function, cancer therapies, and infectious diseases.

The main fields of study associated with Jonathan L. Bramson include Medicine, with subfields such as Oncology, Immunology, Molecular Biology, Infectious Diseases, and Pulmonary and Respiratory Medicine. The research spans several key topics, notably:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 and COVID-19 Research
  • T-cell and B-cell Immunology
  • Viral Infectious Diseases and Gene Expression in Insects
  • Virus-based gene therapy research

Jonathan L. Bramson has published in several frequent venues, prominently including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cytotherapy
  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology
  • OncoImmunology

Their recent papers demonstrate a range of topics within immunotherapy and oncology. Notable publications include:

  • "The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma," 2020, Cell Stem Cell
  • "Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors," 2021, iScience
  • "Metformin-induced reductions in tumor growth involves modulation of the gut microbiome," 2022, Molecular Metabolism
  • "De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors," 2020, Communications Biology
  • "The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy," 2023, Communications Biology

Frequent collaborators in Jonathan L. Bramson's research projects include Joanne A. Hammill, Jessica A. Breznik, Dawn M. E. Bowdish, Ishac Nazy, and Andrew P. Costa. These coauthors have contributed to multiple publications, reflecting sustained research partnerships.

Best Publications

  • Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models

    Raluca Eftimie;Jonathan L. Bramson;David J. D. Earn

  • Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

    J. L. Bramson;M. Hitt;C. L. Addison;W. J. Muller

  • TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection

    Anna Zganiacz;Michael Santosuosso;Jun Wang;Tony Yang

  • Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer

    Chris P. Verschoor;Jennie Johnstone;Jamie Millar;Michael G. Dorrington

  • IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.

    M J Greenberger;S L Kunkel;R M Strieter;N W Lukacs

  • A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity

    Fiona Smaill;Mangalakumari Jeyanathan;Marek Smieja;Maria Fe Medina

  • Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus

    Theodore Oliphant;Grant E. Nybakken;S. Kyle Austin;Qing Xu

  • Potentiating Cancer Immunotherapy Using an Oncolytic Virus

    Byram W Bridle;Kyle B Stephenson;Jeanette E Boudreau;Sandeep Koshy

  • Maraba virus as a potent oncolytic vaccine vector.

    Jonathan G Pol;Liang Zhang;Byram W Bridle;Kyle B Stephenson

  • Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination.

    Yonghong Wan;Jonathan Bramson;Ronald Carter;Frank Graham

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • The use of adenoviral vectors for gene therapy and gene transfer in vivo

    Jonathan L Bramson;Frank L Graham;Jack Gauldie

  • Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen presenting cell properties

    Moïra François;Moïra François;Raphaëlle Romieu-Mourez;Sophie Stock-Martineau;Marie Noëlle Boivin

  • Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL

    Lea Luketic;Jordan Delanghe;Paul T. Sobol;Pingchang Yang

  • The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.

    Parvez Vora;Chitra Venugopal;Sabra Khalid Salim;Nazanin Tatari

  • IL-1α/IL-1R1 Expression in Chronic Obstructive Pulmonary Disease and Mechanistic Relevance to Smoke-Induced Neutrophilia in Mice

    Fernando M. Botelho;Carla M. T. Bauer;Donna Finch;Jake K. Nikota

  • A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo

    Edward M. Bertram;Wojciech Dawicki;Bradley Sedgmen;Jonathan L. Bramson

  • Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.

    J Bramson;K Dayball;C Evelegh;Y H Wan

  • Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

    J. Bramson;M. Hitt;W. S. Gallichan;K. L. Rosenthal

  • Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

    JL Bramson;M Hitt;J Gauldie;FL Graham

Frequent Co-Authors

Yonghong Wan
Yonghong Wan McMaster University
Mark Loeb
Mark Loeb McMaster University
Brian D. Lichty
Brian D. Lichty McMaster University
Zhou Xing
Zhou Xing McMaster University
Jack Gauldie
Jack Gauldie McMaster University
Dawn M. E. Bowdish
Dawn M. E. Bowdish McMaster University
Frank L. Graham
Frank L. Graham McMaster University
Ali A. Ashkar
Ali A. Ashkar McMaster University
Jeffrey A. Medin
Jeffrey A. Medin Medical College of Wisconsin
Jason Moffat
Jason Moffat University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can broaden career opportunities. Many students consider nursing programs designed for career changers, such as the best online bsn programs for non nurses. These programs provide foundational nursing knowledge, a valuable complement to Immunology expertise.

If you are looking for faster routes into nursing, absn programs with high acceptance rates offer accelerated timelines and more accessible admissions. These programs are ideal for students aiming to quickly enter the nursing workforce.

For entry-level healthcare roles, the fastest and easiest lpn programs can be a practical choice. Licensed Practical Nurses play a vital role in patient care coordination, and this credential can be earned with relative speed.

Those seeking advanced practice can explore options like the easiest nurse practitioner program. Becoming a Nurse Practitioner merges clinical expertise with patient management—skills complementary to an Immunology background and beneficial in specialized healthcare settings.

Best Scientists Citing Jonathan L. Bramson

Trending Scientists

Recently Published Articles